Clinical Trials in Houston

Showing 4621-4640 of 17,885 trials

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

NCT05132504

Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab followed by surgery for patients with resectable pancreatic cancer Trial Phase: Phase II Clinical Indication: Pancreatic ductal adenocarcinoma; Adenocarcinoma; AJCC I, II, or III; 1st Line neoadjuvant Trial Type: Interventional prospective Type of control: Historical Route of administration: IV Treatment Groups: Neoadjuvant FOLFIRINOX combined with Pembrolizumab followed by surgery for patients with resectable pancreatic cancer Number of trial participants: 30 Estimated enrollment period: 24 months Estimated duration of trial: 3.5 Years Duration of Participation:16 months Estimated average length of treatment per patient: 16 months

Pancreatic Ductal Adenocarcinoma

Baylor College of Medicine30 participantsStarted Aug 2022

Houston, Texas, United States • Houston, Texas, United States • Houston, Texas, United States

COMPLETED< 1 mile

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

NCT05848817

The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.

Myopia

Mann Eye Institute50 participantsStarted May 2023

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

NCT02131597

This phase II trial studies how well guadecitabine works in treating patients with myelodysplastic syndromes that are at higher risk for becoming acute myeloid leukemia. Guadecitabine may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

High Risk Myelodysplastic Syndrome

M.D. Anderson Cancer Center100 participantsStarted Nov 2014

Houston, Texas, United States

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes

Find Trials by Condition in Houston

9-ING-41 in Pediatric Patients With Refractory Malignancies.

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

ALTO-100 in Bipolar Disorder With Depression (BD-D)

A Study to Compare Nighttime Aligners to Daytime Aligners

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

A Study of RSLV-132 in Females With Sjögren's Disease

A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines

A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver Problems

Expanded Clinical Study of the Tendyne Mitral Valve System

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel